Skip to content Skip to footer

2022

Journal Article

Thiosemicarbazones reprogram pancreatic cancer bidirectional oncogenic signaling between cancer cells and stellate cells to suppress desmoplasia

Richardson, D. R., Azad, M Gholam, Afroz, R., Richardson, V. and Dharmasivam, M. (2022). Thiosemicarbazones reprogram pancreatic cancer bidirectional oncogenic signaling between cancer cells and stellate cells to suppress desmoplasia. Future Medicinal Chemistry, 14 (13), 1005-1017. doi: 10.4155/fmc-2022-0050

Thiosemicarbazones reprogram pancreatic cancer bidirectional oncogenic signaling between cancer cells and stellate cells to suppress desmoplasia

2021

Journal Article

The relationship of glutathione-s-transferase and multi-drug resistance-related protein 1 in nitric oxide (No) transport and storage

Russell, Tiffany M., Azad, Mahan Gholam and Richardson, Des R. (2021). The relationship of glutathione-s-transferase and multi-drug resistance-related protein 1 in nitric oxide (No) transport and storage. Molecules, 26 (19) 5784, 1-27. doi: 10.3390/molecules26195784

The relationship of glutathione-s-transferase and multi-drug resistance-related protein 1 in nitric oxide (No) transport and storage

2021

Journal Article

Calcium channels and iron metabolism: a redox catastrophe in Parkinson's disease and an innovative path to novel therapies?

Boag, Matthew K., Ma, Linlin, Mellick, George D., Pountney, Dean L., Feng, Yunjiang, Quinn, Ronald J., Liew, Alan Wee-Chung, Dharmasivam, Mahendiran, Azad, Mahan Gholam, Afroz, Rizwana and Richardson, Des R. (2021). Calcium channels and iron metabolism: a redox catastrophe in Parkinson's disease and an innovative path to novel therapies?. Redox Biology, 47 102136, 102136. doi: 10.1016/j.redox.2021.102136

Calcium channels and iron metabolism: a redox catastrophe in Parkinson's disease and an innovative path to novel therapies?

2021

Journal Article

The oncogenic signaling disruptor, ndrg1: molecular and cellular mechanisms of activity

Chekmarev, Jason, Azad, Mahan Gholam and Richardson, Des R. (2021). The oncogenic signaling disruptor, ndrg1: molecular and cellular mechanisms of activity. Cells, 10 (9) 2382. doi: 10.3390/cells10092382

The oncogenic signaling disruptor, ndrg1: molecular and cellular mechanisms of activity

2021

Journal Article

Parkinson's disease: alterations in iron and redox biology as a key to unlock therapeutic strategies

Ma, L., Gholam Azad, M., Dharmasivam, M., Richardson, V., Quinn, R. J., Feng, Y., Pountney, D. L., Tonissen, K. F., Mellick, G. D., Yanatori, I. and Richardson, D. R. (2021). Parkinson's disease: alterations in iron and redox biology as a key to unlock therapeutic strategies. Redox Biology, 41 101896, 1-33. doi: 10.1016/j.redox.2021.101896

Parkinson's disease: alterations in iron and redox biology as a key to unlock therapeutic strategies

2020

Journal Article

Ascorbate and tumor cell iron metabolism: the evolving story and its link to pathology

Bae, Dong-Hun, Gholam Azad, Mahan, Kalinowski, Danuta S., Lane, Darius J.R., Jansson, Patric J. and Richardson, Des R. (2020). Ascorbate and tumor cell iron metabolism: the evolving story and its link to pathology. Antioxidants and Redox Signaling, 33 (12), 816-838. doi: 10.1089/ars.2019.7903

Ascorbate and tumor cell iron metabolism: the evolving story and its link to pathology